SubHero Banner
Text

1st Quarter 2024

Key topics in this quarter’s edition include:

  • Fidanacogene elaparvovec (gene therapy) for treatment of hemophilia B 
  • mRNA-1345 vaccine for RSV infection
  • Ensifentrine for treatment of chronic obstructive pulmonary disease (COPD)

Download PDF

Text